Network of Advanced Specialty Healthcare

What Network of Advanced Specialty Healthcare does

NASH is a specialty pharmacy and healthcare services platform headquartered in Omaha, Nebraska, that sources brand-name specialty medications from licensed pharmacies in Tier 1 healthcare countries and resells them to U.S. self-insured employers, PBMs, benefits brokers, and self-pay consumers at 40-60% (and up to 70%) savings versus domestic specialty pharmacy pricing. Its core offerings include an assessment-based specialty pharmacy service (described as its most popular option), a telehealth-enabled pathway, a self-pay direct-to-consumer prescription program, and a Travel-for-Treatment product that arranges surgical procedures at JCI-accredited partner hospitals in Cancun and Monterrey, Mexico. Technology consists of a HIPAA-compliant web-based patient management workflow (initially OnQueue, selected in 2023, and a proprietary in-house portal launched in 2025), supported by cold-chain packaging for temperature-sensitive medications. NASH's go-to-market is sales-led, with dedicated account managers, ERISA-compliant implementation support, and multi-channel distribution via direct employer sales, PBM integration, and broker/consultant partnerships, monetizing through a cost-plus transaction-fee model on each medication fill or per-fill payment for self-pay patients.

Name

Network of Advanced Specialty Healthcare

Legal name

Network of Advanced Specialty Healthcare

Website

https://nashcares.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

NASH is a specialty pharmacy platform that sources brand-name medications from licensed international pharmacies in Tier 1 countries, delivering 40-60% cost savings to self-insured employers, PBMs, brokers, and self-pay patients, and also facilitates travel-for-treatment at JCI-accredited hospitals in Mexico.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Services

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC)

akta.pro secondary industries

Specialty Pharmacy Benefit Management (Specialty PBM) (HLAEAKAE), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Specialty Pharmacy & Biologics Distribution (CRAOAHAD), Copay Assistance, Patient Support & Affordability Programs (HLAEAKAI), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Specialty pharmacy services
• International medication sourcing
• Specialty drug cost management
• Travel-for-treatment healthcare
• Pharmacy benefit solutions

Headquarters

HQ city

Omaha

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Medication Program: NASH sources specialty medications from international pharmacies and provides them to employers/PBMs at reduced costs. The company uses a cost-plus model to provide pharmacy, shipping and other services at the lowest price available and passes remaining savings to clients.
2. Self-Pay Direct-to-Consumer: Cash-paying healthcare consumers can access verified, safe, same-brand specialty medications through NASH's international pharmacy partners. Patients pay for medication fills directly.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Network of Advanced Specialty Healthcare (NASH) sources 450+ brand-name specialty medications from licensed pharmacies in Tier 1 healthcare countries and delivers them to employees/members of self-insured employers, PBMs, and brokers at an average 40–60% cost savings versus U.S. specialty pharmacy pricing, with zero out-of-pocket costs for patients and no therapy interruption. The company also offers Travel-for-Treatment services, arranging surgical procedures and medication dispensation at JCI-accredited partner hospitals in Cancun and Monterrey, Mexico.

Product overview

Network of Advanced Specialty Healthcare (NASH) operates as a specialty pharmacy and healthcare services platform offering multiple interconnected products. The core offering includes Specialty Pharmacy Services providing 450+ brand-name medications with 40-60% cost savings and zero patient out-of-pocket costs, delivered via assessment-based (most popular) or telehealth modalities. Travel-for-Treatment provides surgical procedures at JCI-accredited partner hospitals in Mexico. The platform is supported by a proprietary HIPAA-compliant portal (launched 2025) and the OnQueue Patient Management Platform (selected 2023). Executive Health Programs offer personalized wellness services for employers. Self-pay DTC options extend access to cash-paying consumers. All services are designed for employers, PBMs, brokers, and patients, with NASH serving as the coordinating platform that integrates international pharmacy partners, US employers, and patients into a unified care delivery model.

Differentiator

Problem solved

Functional benefit

Products and services

• Specialty Pharmacy Services Access to 450+ brand-name specialty medications sourced from licensed international pharmacies in Tier 1 healthcare countries, delivered directly to patients of self-insured employers, PBM clients, or self-pay consumers with zero out-of-pocket costs and 40–60% savings versus U.S. specialty pharmacy pricing.
• Travel-for-Treatment Coordinates surgical procedures and medication dispensation for patients who travel to JCI-accredited partner hospitals in Cancun and Monterrey, Mexico, with continuity of care provided by NASH's clinical team and multilingual patient support.
• Assessment-Based Specialty Pharmacy NASH's primary prescription pathway, in which a patient's medical records are reviewed for therapy appropriateness, a prescription aligned with U.S. domestic therapy is written, and the medication is shipped directly to the patient from international partner pharmacies.
• Self-Pay Direct-to-Consumer Program Direct-to-consumer prescription delivery program for cash-paying patients or those whose specialty drugs are not covered by insurance, providing access to verified, manufacturer-sealed same-brand specialty medications at 40–60% savings through NASH's international pharmacy network.
• Executive Health Programs Personalized wellness checkups and prevention-focused healthcare programs designed for executives and leadership teams to detect serious health concerns early and promote proactive health management.

Quantifiable outcome

• Average 40-60% savings on specialty medications for employers/plan sponsors
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core.

• Transparency-RxcoreGTM or Marketing Partner · 18 September 2025NASH joined Transparency-Rx, a not-for-profit coalition of transparent PBMs dedicated to changing drug pricing. NASH joins industry experts and stakeholders embarked on a non-partisan effort to promote real policy changes within the healthcare industry. CEO Joe Shields stated that NASH's focus on drug affordability aligns with Transparency-Rx's mission to change outdated pharmacy benefit and prescription drug policies.
• OnQueuecoreTechnology or Integration · 1 January 2023OnQueue was selected as NASH's Patient Management Platform in 2023. This web-based platform empowers the NASH team to manage patients for surgical and pharmacy services in a streamlined manner using a task-based system.
• Cancun Hospital (Mexico)coreStrategic or Co-development PartnerNASH works with two hospitals in Mexico - one in Cancun and one in Monterrey - that follow Joint Commission International (JCI) standards. The Cancun facility allows NASH's surgical team to perform procedures in their facilities, the only such agreement with a U.S.-based company. This level of partnership assures patients continuity of care leading to superior health outcomes.
• Monterrey Hospital (Mexico)coreStrategic or Co-development PartnerIn Monterrey, NASH partners with medical teams to perform procedures. Due to high accreditation standards and resulting high level of care, this partnership enables quality enhancement opportunities highlighted in the Journal of Healthcare Management article.
• International Pharmacy Partners (Tier 1 Countries)coreStrategic or Co-development PartnerNASH partners with licensed pharmacies in Tier 1 countries that meet NASH's rigorous pharmacy practice standards. These pharmacies are chosen for their dedication to patient-centered care and adherence to exacting quality standards, exceeding requirements. All products dispensed are authentic, manufacturer sealed, and distributed through secure verified supply chains.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Amber Specialty Pharmacy: Specialty pharmacy headquartered in Omaha, NE, previously led by NASH CEO Mike Agostino. Operates in the same specialty pharmacy category serving patients and payers with high-cost therapies, making it the closest comparable by leadership lineage and geography.
• Hy-Vee Pharmacy Solutions: Specialty and infusion pharmacy arm of Hy-Vee, also co-founded/led by NASH CEO Mike Agostino. Competes in specialty medication distribution for employers and health plans with a similar employer-channel focus.
• Capital Rx: Technology-driven transparent PBM offering pharmacy benefit administration to employers and plans. Closely comparable to NASH's positioning around cost transparency and employer-direct specialty drug savings.
• SmithRx: Transparent PBM targeting self-insured employers with pass-through pricing and specialty drug management. Directly comparable in GTM motion (employers + brokers) and PBM reform narrative.
• RxBenefits: Pharmacy benefit partner serving self-funded employer plans and benefits brokers with specialty drug management. Comparable customer base (self-insured employers, brokers) and PBM-adjacent value proposition.

Broad incumbents

• Diplomat Pharmacy: Independent specialty pharmacy serving chronic and complex therapy patients, now part of Optum. Comparable core specialty pharmacy distribution model and patient support programs, but at significantly larger scale.
• Accredo (Express Scripts): Largest U.S. specialty pharmacy by script volume, owned by Express Scripts/Cigna. Directly competes for the same specialty therapy prescriptions that NASH sources, but at vastly larger scale via integrated PBM channel.

Emerging players

• PANTHERx Rare: Specialty pharmacy focused on rare and orphan disease therapies. Comparable specialty pharmacy operations and high-touch patient support model, with overlap on complex high-cost medications.
• BioPlus Specialty Pharmacy: Specialty pharmacy serving patients with complex chronic conditions including oncology, hepatitis, and autoimmune diseases. Comparable specialty medication distribution and patient management focus.

Others

• Transparency-Rx: Not-for-profit coalition of transparent PBMs that NASH joined in 2025. Industry coalition rather than direct competitor, but a relevant peer shaping the regulatory and reputational environment in which NASH competes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@nash-cares
• LinkedInlinkedin.com/company/networkofadvancedspecialtyhealthcare

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Network of Advanced Specialty Healthcare